(Q33344056)

26 July 2017

title

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases (English)

1 reference

26 July 2017

1 reference

1 reference

hepatocellular carcinoma

1 reference

Eiji Ando

1

1 reference

26 July 2017

Masatoshi Tanaka

2

1 reference

26 July 2017

Fumihiko Yamashita

3

1 reference

26 July 2017

Ryoko Kuromatsu

4

1 reference

26 July 2017

Shigeru Yutani

5

1 reference

26 July 2017

Kazuta Fukumori

6

1 reference

26 July 2017

Shuji Sumie

7

1 reference

26 July 2017

Yoichi Yano

8

1 reference

26 July 2017

Koji Okuda

9

1 reference

26 July 2017

Michio Sata

10

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

26 July 2017

1 reference

26 July 2017

volume

95

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

588-595

1 reference

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Angiographic Demonstration of Intrahepatic Arterio-Portal Anastomoses in Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Demonstration of Growing Casts of Hepatocellular Carcinoma in the Portal Vein by Celiac Angiography: The Thread and Streaks Sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Transcatheter oily chemoembolization of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

Rising incidence of hepatocellular carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

Hepatocellular carcinoma with venous invasion. Sonographic-angiographic correlation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

Portal vein involvement in hepatocellular carcinoma: dynamic CT features

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

Microwave coagulation therapy for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

Percutaneous alcohol injection of portal thrombosis in hepatocellular carcinoma: a new possible treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

Chemotherapy for hepatocellular carcinoma with portal hypertension due to tumor thrombus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

Cytoreduction and sequential resection for surgically verified unresectable hepatocellular carcinoma: evaluation with analysis of 72 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

120 hours simultaneous infusion of cisplatin and fluorouracil in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10694

7 January 2021

Identifiers

DOI

10.1002/CNCR.10694

1 reference

26 July 2017

1 reference